Steering committee
Keith Roberts is a hepatobiliary/pancreatic and liver transplant surgeon and honorary professor at the University of Birmingham. He trained in the Birmingham unit and Leeds. He is the Pancreas Subspecialty Lead for Pancreatic Cancer for the Royal College of Surgeons of England, Treasurer to the Pancreatic Society of Great Britain and Ireland and advisor to Pancreatic Cancer UK. He has helped inform the output from the All Parliamentary Group on pancreatic cancer and previously been a member of the HPB Clinical Reference Group for NHS England.
His research focuses upon improving the pathways and experience of those with pancreatic cancer. His team are developing a novel diagnostic test for pancreatic exocrine insufficiency and he is part of a team to study the role of immunology in pancreatic cancer at the University of Birmingham. He is the study lead for the PARANOIA project.
Professor Keith Roberts
Miss Rupaly Pande
Rupaly is a HPB registrar who is currently out of programme for research and undertaking a PhD in “Development of a novel platform for understanding POPF through overcoming barriers to research. (PAncReatic ANastOmosIs Audit: PARANOIA)”. She has been on the steering committee for a national audit of the pancreatic cancer pathway, RICOCHET, and is involved with several clinical studies centred around pancreatic cancer both nationally and internationally. She is a supervisor for intercalated BSc students from the University of Birmingham. Her research focus is around Fast Track Surgery for pancreatic cancer, post-operative pancreatic fistula and developing collaborative work. She is the co-lead for the PARANOIA project.
Mr Arshad is a Consultant Hepatobiliary and Pancreatic surgeon at University Hospital Southampton. This centre manages patients with resectable pancreatic cancer from across the south central coast of England, Isle of Wight and Channel Islands. He has particular expertise in the multimodal management of borderline resectable pancreatic cancer, and is a key member of the only team in the UK delivering intraoperative radiotherapy for any tumour site. Mr Arshad graduated with honours from Cambridge University and pursued surgical training in the East Midlands culminating in a fellowship at the Birmingham liver and pancreatic unit. He was awarded a MD by the University of Leicester for his work in novel biological therapies for advanced pancreatic cancer.
Mr Ali Arshad
Saxon has been an HPB Surgeon at Christchurch hospital, New Zealand since 2005. After completing his RACS training in NZ he spent 4 years in UK completing HPB training (Liverpool and Edinburgh). His research interests have focused on clinical issues including safe cholecystectomy and post pancreatectomy pancreatitis. He is the e-clinical health lead for the Canterbury district health board and has been involved with tech companies bringing electronic workflow solutions for clinicians from concept to production. Since 2008-2021 he has been an Editor of HPB and a member of the editorial boards of the WJS and BJS. He has been on APHPBA council (2012-2019), the research committee of the IHPBA (2012-2020) and board of ANZHPBA (2019-). Recently he has been appointed independent director of Forte Health. He has published over 125 articles including, book chapters and videos
Dr Saxon Connor
Professor Kevin Conlon
.Professor Conlon is Professor of Surgery at Trinity College Dublin, and an HepatoPancreatoBiliary (HPB) consultant surgeon at St. Vincent’s University Hospital, Dublin, Ireland. He is a surgical oncologist with a clinical interest in benign and malignant diseases of the pancreas. He is widely published with over 300 peer-reviewed manuscripts and 50 book chapters. He was Editor-in-Chief of the journal Digestive Surgery from 2013-2021, and currently is on the editorial board of a number of international journals. He is a Past-President of the PSGBI (2011) and the EAHPBA (2019-2021), and currently is the Secretary-General of the IHPBA. He is a member of the Council of the RCS in Ireland. He is also a member of the European Surgical Association and the International Surgical Group. He was awarded the Honorary Fellowship of the American Surgical Association in 2020.
Mr Euan J Dickson
Mr Nicola de' Liguori Carino
Mr Nicola de'Liguori-Carino completed his surgical training in Rome, Italy, and trained in HPB and transplant surgery at Liverpool and Leeds before being appointed as a Consultant in Manchester in 2009. His skills include advanced laparoscopic surgery and Irreversible Electroporation (IRE). He is committed in liver and pancreas cancer research programs taking part in multiple ongoing international clinical trials. A significant effort from him and his team has been put in developing a regional program for fast-track pancreatic surgery for periampullary malignancies. His research interests are also focused on cancer surgery in the elderly improving outcomes and extending boundaries in the field of HPB malignancies. He is first author and co-authors of several original scientific papers published in international journals and is member of several surgical societies.
Dr Francesco Giovinazzo
Dr Giovinazzo is an HPB, Abdominal Multi-organ Retrieval and Liver Transplant Surgeon interested in Hepatobiliary and Pancreatic Cancer research, including Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs). He is currently working as Liver Transplant Surgeon with an additional interest in surgical oncology at the Policlinico A. Gemelli in Rome, Italy. He has been trained in HPB surgery and liver transplantation in UK and Italy. He was awarded a PhD degree from the University of Verona in 2012 . Dr Giovinazzo has been involved in clinical, laboratory-based, epidemiological and meta-analysis projects producing high impact publications, led several international projects, and secured research funds with different research grants.
Professor Ewen Harrison
Ewen Harrison is Professor of Surgery and Data Science at the University of Edinburgh and a Consultant HPB and Transplant Surgeon at the Royal Infirmary of Edinburgh. He is Director of the Centre for Medical Informatics within the Usher Institute, University of Edinburgh. He leads the NIHR Unit on Global Surgery at the University of Edinburgh and has led the analysis of the ISARIC-4C COVID-19 Clinical Characterisation Study. He has an MSc in Statistics and is an Editor for HPB. His work is funded by the NIHR, Wellcome Trust, MRC and Academy of Medical Sciences. He has given the 2019 Global Surgery Seminar at Memorial Sloan Kettering Cancer Center, the British Journal of Surgery Lecture 2017 at the 12th Annual Academic Surgical Congress, the Honyman Gillespie Lecture 2016, and the Macewan Lecture 2016 at the Association of Surgeons of Great Britain and Ireland.
Dr Todd Hore
After gaining FRACS in 2012, Dr Hore underwent post fellowship HPB training in Auckland, Liverpool (UK) and Leeds (UK). He then returned to Christchurch Hospital in 2016 where he works as a HPB surgeon in the Department of General Surgery. Clinical interests include surgical treatment of hepatic, pancreatic and biliary disease. Dr Hore is an honorary lecturer at the Otago University and has a strong interest in quality, education and research.
Mr Stephen Knight
Steve is a NIHR Clinical Research Fellow and surgical registrar in the West of Scotland. Interests include crowd-sourcing patient-level data, machine learning techniques, mobile data collection platforms and wearable technology to measure postoperative surgical outcomes.
During his PhD exploring global surgical outcomes, he helped lead GlobalSurg 3, a prospective international cohort study of early cancer outcomes of 15 000 patients across 82 countries. Recent work developing risk stratification scores to guide clinical management during the Covid-19 pandemic has been published in the British Medical Journal and incorporated within national guidelines.
He also sits on the NIHR Surgical MedTech Cooperative steering committee, leading on surgical innovation to improve postoperative recovery and surveillance in patients with HPB-related diseases.
Dr Benjamin Loveday
Dr Benjamin Loveday is a Hepato-Pancreato-Biliary (HPB) Surgeon at the Royal Melbourne Hospital and Peter MacCallum Cancer Centre, and is Head of the Hepatobiliary and Upper Gastrointestinal Unit at the Royal Melbourne Hospital. He trained in General Surgery in Aotearoa New Zealand, and HPB Surgical Oncology and Abdominal Organ Transplant Surgery in Aotearoa New Zealand and Canada. He has a specific interest in borderline resectable and locally advanced pancreatic cancer. He is regularly involved in multivisceral resections for advanced malignancies. Benjamin has a PhD in Surgery from Waipapa Taumata Rau / University of Auckland.
Dr Laura Magill
Biography awaited
Dr Anubhav Mittal
Professor Darius Mirza
Sanjay is a consultant HPB and Transplant surgeon at the Freeman hospital in Newcastle upon Tyne. He underwent his higher surgical training in the Scotland followed by HPB & Transplant fellowships in Edinburgh and Leeds. His clinical areas of interests are pancreatic cancer and acute pancreatitis with particular emphasis on PROMS in pancreatic cancer and Early management in Acute pancreatitis. He has a strong research portfolio with more than 125 publications and currently hold a position of Associate professor in the University of Auckland, New Zealand and Senior Clinical Lecturer, Newcastle University. He is on the abstract selection committee of the European Pancreas Club and have also hold multiple positions with the Royal College of Surgeons of Edinburgh, including committee member of Surgical Speciality Board and Regional Surgical Adviser
Mr Sanjay Pandanaboyana
Professor Thomas Pinkney
Biography awaited
Professor Jas Samra
Professor Siriwardena studied medicine at the University of Manchester and then trained in General and Hepatobiliary Surgery in Manchester, Edinburgh, Richmond USA and with Professor Henri Bismuth in Paris. He moved to his current position as Consultant Surgeon at the Manchester Royal Infirmary in 1999 and was appointed Professor of Hepatobiliary Surgery at the University of Manchester in 2008. In 2007 he received the prestigious “Silver Scalpel” award as the best surgical trainer in the UK. His clinical practice is in Hepato-pancreato-biliary oncological surgery with a clinical focus on liver and pancreas cancer surgery. He has research interests in pancreatic inflammatory disease and in metastatic colorectal cancer. He was the congress President for E-AHPBA 2015 is the President-elect of E-AHPBA.
Professor Ajith Siriwardena
Professor Sohei Satoi
Dr. Sohei SATOI is a pancreato-biliary surgeon and surgical oncologist more than 20 years of experience. He is internationally recognized as a leader in the surgical treatment of pancreatic ductal adenocarcinoma including
unresectable disease, as well as in multimodal treatment of peritoneal dissemination. Dr. Satoi is also keen to developing mitigation strategy of post-pancreatectomy complications. He is active in academic research with
more than 180 peer reviewed papers, and is a member of several scientific journal's editorial boards. His mission is to bring "cure" patients with pancreatic ductal adenocarcinoma, and zero-mortality and less incidence of
surgical complication after pancreatectomy.
Stefan Stättner started his general and vascular surgical training in Vienna and a senior clinical fellowship at the University hospital Aintree in Liverpool/UK. After 4 years at the Paracelsus Medical University in Salzburg setting up the supraregional HPB Service and finishing his scientific thesis (Venia docendi) in 2014 about “extending resectability in primary and secondary liver tumours” he moved to the Medical University of Innsbruck, where he was the clinical Lead for surgical HPB Oncology and in charge of research in this field of surgical oncology. Since February 2021 he is Head of Department of General, Visceral and Vascular Surgery at the Salzkammergut Kliniken. Stefan Stättner is active in E-AHPBA and ESSO educational committees, EORTC GI Cancer task force and ENETS and acts in the CIEMAR steering committee. He has been organizing several national and international educational meetings, always emphasizing the practical needs for HPB surgeons.
Dr Stefan Stättner
Mr Robert P Sutcliffe
Robert Sutcliffe studied medicine at Cambridge University and qualified in 1995. He underwent general surgery training in London and specialist training in hepatobiliary and pancreatic surgery at Kings College and Royal London Hospitals. He was appointed as a Consultant in hepatobiliary and pancreatic surgery at UHB in 2011. He undertakes the full range of HPB procedures and has a special interest in laparoscopic HPB surgery. Robert has also implemented a laparoscopic adrenalectomy service at UHB, and is the surgical lead for adrenal surgery. Robert has an interest in perioperative care, and has been involved in developing enhanced recovery pathways in HPB surgery within the unit.
Professor Bobby Tingstedt
Bobby Tingstedt is Professor of Surgery at Lund University, Sweden and Clinical lead of HPB unit Skåne University Hospital Lund, Sweden. He has been a HPB surgeon since 2001. He has written over 80 peer-reviewed published articles. His primary an interest in pancreatic surgery and perioperative course. He is the Chairman of The Swedish National Pancreatic and periampullary Cancer Registry since 2016 and Chairman of the Swedish National Program for Pancreatic Cancer since 2017